Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Pentoxifylline Extended-Release Tablets USPRx only
Medication labelWhy this: Advisory · dailymed-prescription
Pentoxifylline Extended-Release Tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline Extended-Release Tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.
- generic_name
- pentoxifylline
- product_names
- Pentoxifylline
- ndc
- 70954-668, 70954-668-10, 70954-668-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en